ProShares Ultra Nasdaq Biotechnology Rating $56.86 -0.24 (-0.42%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$56.86 0.00 (0.00%) As of 02/21/2025 05:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends ProShares Ultra Nasdaq Biotechnology Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BIB Aggregate RatingModerate Buy 2.71Holdings in BIB have an aggregate rating of Moderate Buy based on 670 analyst ratings issued in the past year covering 42 companies (57.0% of the portfolio).BIB Aggregate Price Target$56.86High Prediction$56.86Average Prediction$56.86Low Prediction$56.86Holdings in BIB have an aggregate price target of $56.86 and a range of $56.86 to $56.86 covering 42 companies (57.0% of the portfolio).BIB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy11 Buy rating(s)Moderate Buy25 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ProShares Ultra Nasdaq Biotechnology Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 42 BIB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.45%AMGNAmgen$303.01+1.7%4.4751 of 5 stars2.46$314.09 3.7%24Insider TradePositive News6.44%GILDGilead Sciences$109.95-0.1%4.7947 of 5 stars2.72$102.08 -7.2%29Analyst UpgradeInsider TradeOptions VolumeAnalyst RevisionPositive News6.23%VRTXVertex Pharmaceuticals$484.24+0.8%4.1169 of 5 stars2.65$505.61 4.4%26Analyst DowngradeInsider TradeAnalyst RevisionPositive News5.51%REGNRegeneron Pharmaceuticals$700.33+0.6%4.6674 of 5 stars2.76$973.13 39.0%25Dividend Announcement3.01%AZNAstraZeneca$74.20-0.5%2.6758 of 5 stars3.10$89.75 21.0%10Options Volume2.56%ALNYAlnylam Pharmaceuticals$250.59-0.2%4.4628 of 5 stars2.72$299.48 19.5%25Analyst ForecastInsider Trade1.50%ARGXargenx$644.48-0.5%2.5007 of 5 stars2.86$658.39 2.2%22News CoveragePositive News1.48%BIIBBiogen$140.64+2.6%4.7515 of 5 stars2.43$211.85 50.6%30Analyst Forecast1.26%ILMNIllumina$94.20-3.1%4.7855 of 5 stars2.62$159.45 69.3%211.15%SNYSanofi$54.46+0.6%3.9176 of 5 stars3.25$60.00 10.2%4Analyst RevisionPositive News1.12%UTHRUnited Therapeutics$361.10-1.7%4.3818 of 5 stars2.67$388.25 7.5%12Insider TradePositive News1.06%SMMTSummit Therapeutics$22.12-4.1%2.3077 of 5 stars2.86$33.57 51.8%7Gap Up1.03%INSMInsmed$81.06-3.0%4.0523 of 5 stars3.00$91.00 12.3%15Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews Coverage1.03%INCYIncyte$72.05+0.9%4.541 of 5 stars2.35$75.59 4.9%201.01%RPRXRoyalty Pharma$33.42+0.3%4.5708 of 5 stars3.00$41.60 24.5%6Positive News0.97%ITCIIntra-Cellular Therapies$128.60+0.0%3.916 of 5 stars2.53$103.62 -19.4%15Earnings ReportAnalyst ForecastNews Coverage0.92%VTRSViatris$11.25+1.7%2.3267 of 5 stars2.00$13.67 21.5%3News Coverage0.90%MRNAModerna$35.53+5.3%4.7405 of 5 stars2.04$60.63 70.6%23Analyst DowngradeOptions Volume0.89%NBIXNeurocrine Biosciences$120.69+3.9%4.9825 of 5 stars2.83$166.90 38.3%23Analyst DowngradeBuyback AnnouncementAnalyst RevisionGap Up0.87%BMRNBioMarin Pharmaceutical$68.25-0.7%4.9188 of 5 stars2.70$93.81 37.4%23Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.83%BNTXBioNTech$120.01+1.8%2.39 of 5 stars2.88$142.72 18.9%17Positive NewsHigh Trading Volume0.79%MEDPMedpace$340.78-1.2%4.275 of 5 stars2.45$381.44 11.9%110.78%PCVXVaxcyte$79.74-3.3%2.594 of 5 stars3.00$127.71 60.2%8Insider TradePositive News0.77%SRPTSarepta Therapeutics$106.28-2.0%4.5118 of 5 stars2.87$176.77 66.3%23Upcoming Earnings0.75%TEMTempus AI$68.09-11.2%1.384 of 5 stars2.67$58.55 -14.0%12Upcoming EarningsInsider Trade0.69%EXELExelixis$36.85+5.0%4.5093 of 5 stars2.55$37.24 1.0%20Analyst UpgradeInsider Trade0.57%ROIVRoivant Sciences$10.68-0.4%2.5595 of 5 stars3.00$18.08 69.3%7Insider Trade0.52%HALOHalozyme Therapeutics$57.75+0.5%4.4627 of 5 stars2.60$62.78 8.7%10Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.52%ASNDAscendis Pharma A/S$152.43-1.4%3.1733 of 5 stars2.93$197.36 29.5%14Analyst Forecast0.52%MDGLMadrigal Pharmaceuticals$336.23-4.2%3.2942 of 5 stars2.69$351.67 4.6%130.52%JAZZJazz Pharmaceuticals$136.01-0.5%4.9068 of 5 stars2.93$180.33 32.6%15Upcoming EarningsNews CoveragePositive News0.51%RVMDRevolution Medicines$41.34-2.2%4.5121 of 5 stars3.08$66.25 60.3%12Positive News0.48%BPMCBlueprint Medicines$92.25-2.2%2.9944 of 5 stars2.65$123.83 34.2%20Earnings ReportAnalyst Upgrade0.43%BBIOBridgeBio Pharma$36.85+0.1%4.8297 of 5 stars2.92$51.67 40.2%13Earnings ReportAnalyst ForecastInsider TradeNews CoverageGap Up0.40%NUVLNuvalent$79.49-3.5%2.1161 of 5 stars2.86$112.36 41.4%14Upcoming EarningsInsider Trade0.39%GHGuardant Health$42.87-9.6%4.2489 of 5 stars3.00$44.78 4.5%18Earnings ReportAnalyst ForecastNews CoverageGap UpHigh Trading Volume0.37%AXSMAxsome Therapeutics$137.75+6.7%4.5314 of 5 stars3.00$157.64 14.4%15Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.37%ALKSAlkermes$35.33-0.5%3.6896 of 5 stars2.82$38.36 8.6%110.36%CYTKCytokinetics$50.26-1.7%4.1939 of 5 stars2.94$82.00 63.2%18News Coverage0.36%IONSIonis Pharmaceuticals$32.33-1.1%4.4271 of 5 stars2.70$60.00 85.6%20Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.32%VRNAVerona Pharma$67.96+5.9%1.9177 of 5 stars3.13$57.14 -15.9%80.32%KRYSKrystal Biotech$187.86+2.9%4.4803 of 5 stars3.00$210.00 11.8%8Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage This page (NASDAQ:BIB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIB Stock Alerts